Maxillofacial Enlargement in Secondary Hyperparathyroidism Successfully Treated by Limited Parathyroidectomy and Paricalcitol / 대한신장학회지
Korean Journal of Nephrology
; : 671-675, 2011.
Article
in En
| WPRIM
| ID: wpr-162483
Responsible library:
WPRO
ABSTRACT
Maxillary enlargement is a rare complication of secondary hyperparathyroidism (SHPT). A 35-year-old Korean man undergoing chronic hemodialysis presented with a painless enlargement involving the maxilla and mandible. Plain radiography and CT scan showed bony expansion at the maxilla and mandible with multiple radiolucency. Serum intact parathyroid hormone (iPTH) was >1,600 pg/mL. Tc-99m sestamibi (MIBI) parathyroid scan and neck sonogram were compatible with SHPT. He underwent limited parathyroidectomy and commenced a course of paricalcitol. Fifteen months after surgery, maxillary enlargement and bony resorptions involving both hands markedly improved. Thirty-six months after the surgery, the serum iPTH level was 109.3 pg/mL. This is the first report in Korea documenting a patient with maxillary enlargement in SHPT who was successfully treated with limited parathyroidectomy and paricalcitol.
Key words
Full text:
1
Database:
WPRIM
Main subject:
Parathyroid Hormone
/
Chronic Kidney Disease-Mineral and Bone Disorder
/
Ergocalciferols
/
Parathyroidectomy
/
Renal Dialysis
/
Hand
/
Hyperparathyroidism
/
Hyperparathyroidism, Secondary
/
Korea
/
Mandible
Limits:
Adult
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Korean Journal of Nephrology
Year:
2011
Document type:
Article